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Professor Robert Schrier is one of the two recipients
about to receive the International Society of Nephrolo-
gy’s Jean Hamburger Award for “outstanding research
in nephrology with a clinical emphasis.”
Bob Schrier is a phenomenon endowed with a Hercu-
lean capacity to achieve. His immense contributions to
nephrology, medicine, and medical education remind
one of Osler, particularly because of his emphasis on
the importance of the patient. He has published many
hundreds of papers, but only has 42 books to his credit.
Today, he is being honored for the quality of his research.
Dr. Schrier’s research has spanned three main areas:
vasopressin and body fluid regulation, acute ischemic
renal injury, and hypertension in polycystic kidneys and
type 2 diabetes mellitus.
But, to begin at the beginning, Dr. Schrier was born
in Indiana and received his medical education at the
Indiana School of Medicine. During this time, he was
such an accomplished athlete, particularly playing bas-
ketball, that he nearly became a professional. Fortu-
nately, for medicine, if not for his income, he continued
in medicine. Within 2 years of qualifying, he became a
research fellow at the Peter Bent Brigham Hospital in
Boston, where his interest in those factors which influ-
ence sodium excretion were aroused.
Later, he studied the sodium retention that accompan-
ies various forms of circulatory disorders, such as heart
failure. He noted that in these conditions, as sodium was
retained, the osmolality of the urine changed indepen-
dently of the osmolality of the plasma. This led to his
hypothesis that nonosmotic release of arginine vasopres-
sin was probably responsible for the hyponatremia of
severe heart failure and of advanced cirrhosis of the
liver.
This illustration (Fig. 1) from one of his papers shows
that in patients with severe cardiac failure, plasma vaso-
pressin is raised, although the plasma osmolality is low.
Normal subjects with a plasma osmolality below 280
mOsm/kg have a plasma vasopressin below 0.5 pg/mL.
It can be seen that most of the patients, although their
plasma sodium was low, had a raised plasma vasopressin.
This was a very neat clinical demonstration that non-
osmotic forces can stimulate the secretion of vasopressin.
Similar findings in patients with liver disease led to
the demonstration that the afferent stimulus for both
sodium retention and the nonosmotic release of vaso-
pressin in advanced cirrhosis is vasodilatation.
Fig. 1. Plasma arginine vasopressin in cardiac failure with hyponatremia
To understand Dr. Schrier’s demonstration that in pa-
tients with advanced cirrhosis it is the vasodilatation that
is stimulating the release of vasopressin, it is necessary
to appreciate that, when such a vasodilated patient is
standing or sitting, the widespread vasodilatation gives
rise to a diminution of the volume of blood contained
in the heart and lungs. In other words, in a vasodilated
patient, the volume changes in the chest are the same
as those that occur with volume depletion, as in hemor-
rhage.
In order to demonstrate that the rise in plasma vaso-
pressin in advanced liver disease was due to the vasodila-
tation, Dr. Schrier sat cirrhotic patients in a tank of water
up to their necks. When an individual is placed in this
position, some of the blood in the legs and abdomen is
pushed upward into the chest by the weight of the water.
In a grossly vasodilated individual, such an internal trans-
fusion of blood into the chest changes the perception of
the intrathoracic cardiovascular volume receptors from
one of dearth to one of abundance. In a cirrhotic patient,
this switches off the exaggerated release of vasopressin
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Fig. 2. Hugh de Wardener and Richard W. Schrier
from the hypothalamus, lowers the level of plasma vaso-
pressin, urine flow increases, and plasma sodium rises,
brilliantly demonstrating that the hyponatremia in cir-
rhosis is due to the nonosmotic release of vasopressin
due to vasodilatation.
Dr. Schrier’s work on acute ischemic renal cell injury
began with various clinical studies early in his career in
the 1960s when he was in the Army. In the last few years,
it has culminated in the demonstration that the proximal
tubule damage associated with renal ischemia is due in
part to a rise in intracellular calcium and that this injures
the cell by activating certain intracellular proteases and
caspases. Recently, this conclusion has been supported
by finding that caspase knockout mice are protected
against ischemic renal injury.
The work on hypertension has included a series of
clinical studies and several large prospective randomized
trials lasting several years, which have demonstrated that
in both these conditions aggressive control of the blood
pressure decreases both the renal and the cardiovascular
complications. Aggressive control means keeping the
blood pressure below 128/75 mm Hg.
The results in diabetes are particularly interesting and
potentially explosive. To begin with, they confirm that
blood pressure control in established diabetic nephropa-
thy will slow the deterioration of renal function. But they
also confirm that in diabetic patients with normal kidneys
(i.e., no proteinuria), rigid control of the blood pressure
below 128/75 mm Hg will delay the onset of nephropathy.
For how long, of course, is still in question, but this is a
most fascinating observation.
These are only a few of the reasons why Professor
Schrier is receiving the Jean Hamburger Award.
